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  ABSTRACT 
    Two simple, accurate and sensitive spectrophotometric methods were carried out to investigate through charge-transfer 
reactions of risperidone (RIS) as n-electron donor with various π acceptors: 7, 7, 8, 8-tetracyanoquinodimethane (TCNQ) 
and p-chloranilic acid (pCA). The absorbance of reaction product was measured at 842 and 520 nm for TCNQ and pCA 
reagents respectively. Different experimental parameters affecting the reactions were carefully studied. The reaction 
pathway was postulated. The proposed spectrophotometric method was utilized for the analysis of RIS in pure form as 
well as in its pharmaceutical preparations. Under the optimum reaction conditions, Beer’s law is obeyed over the 
concentration range of 1-12 µg mL
-1
 and 10-180 µg mL
-1
 for TCNQ and pCA respectively. The limit of assays detection 
(LOD) is 0.114 µg mL
-1
 and 2.55 µg mL
-1 
for TCNQ and pCA respectively. The mean recovery percentage was 99.72 ± 
1.06 and 100.50 ± 1.07 for TCNQ and pCA respectively. The results were compared favorably with those obtained by 
comparison method. The proposed method was validated statistically according to ICH guidelines. 
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1. INTRODUCTION 
     Risperidone (RIS) is belonging to the chemical class of Benzisoxazole derivatives and  chemically is 4-(2-(4-(6-
Flurobenzo[d]isoxazd-3yl]1-piperidyl]ethyl]-3-methyl-2,6 diazabicyclodeca-1,3-dien-5-one [1] with molecular formula C23 
H27 FN4O2 was presented in  (Fig. 1) RIS is an antipsychotic agent [2], which acts through selective antagonism of 
serotonin 5HT2, dopamine D2 receptors, used in the treatment of schizophrenia and other psychoses [3].       It is mostly 
metabolized by alicyclic hydroxylation and oxidative N- dealkylation [4]. An ideal stability indicating method is one that 
quantifies the drug and also resolves its degradation products [5]. Literature review for RIS analysis revealed several 
methods based on different technique such as HPLC with UV detection [6].Visible spectrophotometric methods [7], LC-ms 
and HPLC ESI/MS assay for its quantification in plasma and serum [8-11], Chiral Chromatography [12], Pulse 
Polarography [13], Chemiluminescence assay [14], LC with coulometric Detection [15].  
  Since the other reported methods are either tedious [6] or time consuming [8-15], this encourage us to develop simple, 
sensitive and specific spectrophotometric methods for the determination of RIS in bulk drug and different pharmaceutical 
formulations. 
   The proposed methods are based on the charge transfer complexation reaction of RIS with either 7, 7, 8, 8-
tetracyanoquinodimethane (TCNQ) or p- chloranilic acid (pCA) respectively without prior extraction step. The proposed 
methods were validated statistically. 
2. EXPERIMENTAL 
2.1. Apparatus 
   UV-1601PC (Shimadzu, Japan) ultraviolet–visible spectrophotometers with matched 1-cm matched quartz cells, and 
spectro UV, Vis double beam pc scanning spectrophotometer uvd, 2950. 
2.2. Materials and reagents 
    Risperidone was used as working standard. The standard solution was prepared by dissolving 10 mg of the drug in 100 
mL of methanol in case of TCNQ and 100 mg of the drug in 100 mL of acetonitrile in case of pCA, respectively. 
   All other reagents used were of Analytical Reagent grade. Solutions of TCNQ was (0.1%) in acetonitrile and the solution 
was stable for at least 1 week at 4 ◦C and pCA was (0.3%) in acetonitrile, and the solution was freshly prepared. 
2.3. Pharmaceutical preparation  
    Sigmadone
®
 tablets product of (SIGMA pharmaceutical industries, Egypt, S.A.E.), labeled to contain 3 mg RIS per 
tablet, with batch ≠ 00846. 
   Riscure 4
®
 tablets product of (GLOBAL NAPI PHARMACEUTICALS (GNP), Egypt), labeled to contain 4 mg RIS per 
tablet, with batch ≠ 112521A. 
   Psychodal
®
 solution (DELTA PHARMA S.A.E., Egypt), each mL contains 1 mg RIS, with batch ≠ 11492. 
   All pharmaceutical preparations were obtained from local pharmacy. 
2.4. Procedure for determination 
2.4.1. TCNQ method 
    Aliquots of RIS (0.01%) corresponding to 10 µg mL
-1  
with final working range (1-12 µg mL
-1 
 ) were transferred to a 
serious of 10 ml volumetric flasks. To each flask, 1.5 mL of (0.1%) TCNQ was added and heated at 90 ͦ C for 5 min then 
completed to volume with acetonitrile. The absorbance of the colored product was measured at 842 nm against reagent 
blank prepared simultaneously. Calibration curve was obtained by plotting the concentration of the drug versus 
absorbance; alternatively corresponding regression equation was derived. 
2.4.2. PCA method 
  Different aliquots of RIS (0.1%) corresponding to 100 µg mL
-1
 with final working range (10-180 µg mL
-1 
) were transferred 
to a serious of 10 volumetric flasks. To each flask, 4 mL of (0.3%) pCA was added and complete to volume with 
acetonitrile. The absorbance of the colored product was measured at 520 nm against reagent blank prepared 
simultaneously. Calibration curve was obtained by plotting the concentration of the drug versus absorbance; alternatively 
corresponding regression equation was derived. 
2.5. Analysis of pharmaceutical formulations 
2.5.1. Preparation of tablets sample 
    Ten tablets of each formulation were weighed and finely pulverized and mixed well. A quantity of the powder equivalent 
to 10 mg and 100 mg was transferred into a 100 mL conical flask and extracted with 3x30 mL of either methanol or 
acetonitrile for TCNQ or pCA respectively via sonicator for 5 min, filtered into 100 mL measuring flask and completed to 
volume with the corresponding solvent then shaked well. 
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A measured volume of the filtrate was diluted quantitatively with a suitable conc. lies in the linear range of each particular 
assay method. 
   Then the procedures described under section 2.4.1 and 2.4.2 was performed. The nominal content of the drug was 
determined from the corresponding calibration curve or regression equation.  
2.5.2. Preparation of oral solution sample 
     Aliquots of Psycodal oral solution (1mg/mL) were taken and dissolved in 10mL chloroform and shacked for 10 min, and 
then the chloroform layer was separated and evaporated on water bath till dryness. The residue was reconstituted in 
acetonitrile and the absorbance was measured at the specific wavelength. Then the procedures described under section 
2.4.1 and 2.4.2 was performed. The nominal content of the drug was determined from the corresponding calibration curve 
or regression equation.  
2.6. Determination of molar ratio 
   The Job’s method of continuous variation was employed [16]. Standard solutions of RIS and reagents were prepared. 
The concentrations of these solutions were 0.5×10
−3
M (in methanol for TCNQ), 5×10
−3
M (in acetonitrile for pCA). The 
reactions were allowed to proceed for the optimum reaction time and then the absorbance of the resulting solutions was 
measured at the corresponding wavelengths of maximum absorbance (λmax). Fig (2) 
3. RESULTS AND DISSCOSSION 
  Different experimental parameters affecting development and stability of reaction product were carefully studied while 
others were kept constant. These parameters include; effect of reaction time, temperature, solvent, and volume of the 
reagent. 
3.1. Spectral characteristics of the reaction (reaction with π receptors) 
    In polar solvents such as methanol or acetonitrile, complete electron transfer from the RIS (D), as an electron donor, to 
the acceptor moiety (A) takes place with the formation intensely colored radical ions with high molar absorptivity values, 
according to the following scheme: 
                                                                D+A   ↔  (D-A)  ↔    D+  +  A- 
                                                                           Complex     Radical ions 
        the dissociation of the (D-A)complex was promoted by the high ionizing power of the polar solvents and the resulting 
peaks in the absorption spectra of RIS- acceptor reaction mixtures. 
   The interaction of RIS with π-acceptors at 90 ͦ C and at room temperature produced colored chromogenes exhibiting 
maximum absorption at 842, 520 nm for TCNQ and pCA, respectively. Fig (3) 
       The predominant chromogen with TCNQ in acetonitrile is the green colored anion, which exhibits maxima peaking at 
842 and 762 nm. These bands may be attributed to the formation of the radical anion TCNQ•, which was probably formed 
by the dissociation of an original donor-acceptor (D-A) complex with the RIS. The dissociation of the complex was 
promoted by the high ionizing power of acetonitrile. 
  Chloranilic acid (pCA) exists in three ionic forms, the neutral yellow-orange H2A at very low pH, the dark purple HA- 
which is stable at high pH; these transformations are illustrated in the following scheme: 
                                                             H2A  ↔ H
+
  +  HA
-
 (violet), 
                                                             HA
-
 ↔ H
+ 
  + A
2-
(colorless)                                                                                                    
  
      Since the interaction of RIS with pCA in acetonitrile gave red-orange product, it might be concluded that HA
-
 was the 
form of pCA involved in the reaction described herein. 
3.2. Effect of the reaction time and temperature 
      The effect of time on the complexation reactions at room temperature was examined. It was observed that the 
maximum and stable absorbance of RIS-TCNQ was achieved after heating at 90 ͦ C for 5 min., whereas maximum and 
stable absorbance for RIS-pCA was obtained at once at room temperature.  
3.3. Effect of solvent 
    The effect of solvents such as acetonitrile, acetone and methanol on the absorbance of reaction product was studied. 
Experimental results indicated that acetonitrile was the solvent of choice for TCNQ and pCA. Methanol was the solvent of 
choice for RIS in case RIS-TCNQ complex and acetonitrile was the solvent of choice in case of RIS-pCA complex 
regarding stability and maximum absorption of the reaction product.  
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3.4. Effect of reagent volume and concentration 
     The optimum conditions for the TCNQ and pCA methods were established by varying the volume of reagent and 
keeping the drug concentration constant. 
     To establish the optimum experimental condition for RIS-TCNQ charge transfer complex, the drug was allowed to react 
with varying volumes of (0.1%) TCNQ. The maximum absorbance was achieved with 1.5mL and further increase in the 
volume resulted in a gradual decrease in the absorbance value. Therefore a volume of 1.5mL was used as an optimum 
volume. 
     Regarding pCA method, it was found that increasing in the volume of (0.3%) pCA resulted in a gradual increase in the 
absorbance of the reaction product up to 4 mL and after which the absorbance of the reaction product remained constant, 
therefore, 4 mL of pCA was chosen as the optimum volume of the reagent.  
3.5. Development and validation of the analytical methods  
   The validity of the proposed method was tested regarding linearity, specificity, accuracy, repeatability and precision 
according to ICH Q2B recommendations [17]. 
3.5.1. Linearity 
   Using the above procedure, a linear regression equation was obtained. The regression plot showed that there was a 
linear dependence of the absorbance on the concentration of the drug. Linear regression analysis of the data gave the 
following equation: 
                                              A = - 0.0547 + 0.088 C   (r = 0.9999)      for TCNQ      
                                              A = 0.0205 + 0.0047 C   (r = 0.9999)       for pCA   
   Where the A is the absorbance, C is the concentration of the drug in µg mL
-1
 and r is the correlation coefficient. The limit 
of quantitation (LOQ) and limit of detection (LOD) were calculated according to ICH Q2B and results are shown in (table 
1). The values of LOQ and LOD were calculated according to the following equation (17)  
                                                  LOQ = 10 (S.D. a / b);   LOD = 3.3 (S.D. a / b) 
     Where a is intercept of regression line and b is the slope of the calibration curve.  
The proposed method was evaluated for accuracy as percentage relative error (% error) and the precision as percentage 
relative standard deviation (% RSD). (Table 1)                                  
3.5.2. Accuracy  
     To test the validity of the proposed method it was applied to the determination of pure samples of RIS over the working 
concentration range. The results obtained were in a good agreement with those obtained using comparison method [20]. 
Using student t-test and variance F-test revealed no significant difference between the performance of the two methods 
regarding the accuracy and precision, respectively [21]. (Table 3) 
     The comparison method was based on preparation of the stock by transfer 100 mg to 100 mL volumetric flask and 
complete to the volume with methanol and measure the absorbance directly. The absorbance of the reaction product was 
measured at 240 and 280 nm and the concentration was rectilinear over the range of 20 to 60 µg mL
-1 
[20]. 
     The validity of the method was proven by statistical evaluation of the regression lines regarding the standard deviation 
of the residuals (S y/x), the standard deviation of the intercept (Sa) and the standard deviation of the slope (Sb). The results 
are summarized in (table 1).  
    The small values for these figures point to low degree of scattering of the points around the calibration line and high 
precision. 
3.5.3. Precision 
    The repeatability was determined by applying the proposed method for the determination of three concentrations of RIS 
in the pure form three successive times, and the results are listed in (table 2). Low percentage error and low percentage 
RSD indicate high accuracy and high precision of the proposed method [18-19]. 
3.5.4. Robustness 
    The robustness of the method was assessed by evaluating the influence of small variation of experimental variables: 
concentrations of acceptor reagent, and reaction time, on the analytical performance of the method. In these experiments, 
one experimental parameter was changed while the other parameters were kept unchanged, and the recovery percentage 
was calculated each time. The small variations in any of the variables did not significantly affect the results; recovery 
percentage in case of TCNQ is 99.73 ± 0.90 and in case of pCA is 100.50 ± 1.07. This provided an indication for the 
reliability of the proposed methods during routine work. 
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3.6. Application of the proposed method to the analysis of the pharmaceutical preparations 
  The proposed method was applied to the determination of RIS in pharmaceutical preparations. The method was tested 
for linearity, specifity, accuracy, repeatability and precision according to ICH Q2B recommendations [17]. 
3.6.1. Selectivity 
    The selectivity of the method was investigated by observing any interference encountered from the common tablet 
excipients. These excipients did not interfere with the proposed method. 
3.6.2. Accuracy 
    The results of the proposed method were statistically compared with those obtained using the comparison method [20]. 
Statistical analysis of the results, using Student t-test and variance ratio F-test revealed no significant difference between 
the performance of the proposed and the comparison method regarding the accuracy and precision. 
3.7. Application of the method to the analysis of tablets 
   The obtained satisfactory validation results made the proposed procedures suitable for the routine quality control 
analysis of RIS. The proposed and the reported methods were applied to the determination of RIS in its tablets. The 
results obtained by the proposed methods were statistically compared with those obtained by the comparison method at 
which  
     In the t- and F-tests, no significant differences were found between the calculated and theoretical values of both the 
proposed and the reported methods at 95% confidence level [21]. This indicated similar precision and accuracy in the 
analysis of RIS in its tablets. It is evident from these results that all the proposed methods are applicable to the analysis of 
RIS in its tablets with comparable analytical performance. However, the critical recommendations of some of these 
methods might be based on the experimental conditions (e.g. reaction time), and the ultimate sensitivity that determines 
the amount of specimen required for analysis. For example, the method involving pCA is recommended whenever rapid 
analysis is required; this because they have very short reaction time. The method involving TCNQ is recommended, as 
high sensitivity is required on the expense of the analysis time. 
4. CONCLOSION 
      The charge-transfer complexation reaction of risperidone (RIS) as electron donor and some electron acceptors has 
been investigated. The obtained complexes were studied by ultraviolet–visible spectrophotometry technique. The obtained 
colored complexes were utilized in the development of two simple, rapid and accurate spectrophotometric methods for the 
analysis of RIS in pure form as well as in tablets and oral solution. 
 
Table 1: Analytical performance data for the proposed method. 
Parameters TCNQ pCA 
Linearity range(µg mL
-1
) 1-12 10 – 180 
Limit of detection (LOD) µg mL
-1
 0.0999 2.5548 
Limit of quantification(LOQ) µg mL
-1
 0.3027 7.7417 
Intercept (a)                 -0.0547 0.0205 
Slope (b) 0.0881 0.0047 
Correlation coefficient 0.9999 0.9999 
Standard deviation of residual    S (y ̸ x)  
0.0038 
0.0054 
 
Standard deviation of intercept  (Sa ) 0.0027 
 
0.0036 
 
Standard deviation of slope (Sb) 0.0004 0.0000 
% RSD 0.906 1.06 
% Error 0.320 0.38 
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Table 2: Accuracy and precision data for the proposed method. 
Reagent 
 
Concentration 
added 
(µg mL
-1
) 
    Mean of   % 
Recovery 
% RSD % Error 
TCNQ 
Inter-day 
2 100.04 0.86 0.50 
5 101.99 1.05 0.61 
8 98.34 0.29 0.17 
Intra-day 
2 98.95 0.59 0.34 
5 100.14 1.04 0.60 
8 98.58 0.51 0.29 
pCA Inter-day 40 101.37 0.60 0.35 
 
 
 
 
80         99.57 1.16 0.67 
120 98.94 0.34 0.2 
Intra-day 
40 99.57 0.56 0.33 
80 101.97 1.98 1.14 
120 99.62 1.23 0.71 
 
 
 
Table 3: statistical analysis of the results of pure sample using proposed method and comparison method. 
Parameters                                           Spectrophotometric method using 
% Recovery TCNQ pCA 
Proposed method Comparison method Proposed method Comparison method 
98.41 
99.18 
101.06 
99.18 98.58 101.60 
100.37 100.53 
100.14 
101.03 
98.27 
100.03 
101.04 100.98 
99.34  101.29  
100.19 
99.79 
100.60 
99.79 
99.76 99.70 
X ( mean) 
 
99.73 
 
100 
 
100.50 
 
100 
 
± S.D. 
0.90 0.94 1.07 0.94 
Student t- test 0.35 (1.83)* 0.71 (1.83)* 
Variance ratio 
 F- ratio 
0.988 (4.74)* 0.78(4.74)* 
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Table 4: Application of the proposed method to the pharmaceutical preparation using TCNQ. 
Parameters Riscure ( 4 mg) 
(a)
 Sigmadone ( 3 mg)
 (b)
 
%Recovery 
Proposed method Comparison method Proposed method Comparison method 
98.81 99.00 100.71 99.00 
100.29 101.00 101.95 101.00 
99.21 99.67 99.63 99.67 
Mean 99.44 99.89 100.76 99.89 
        ± S.D. 
 
             0.77              1.02            1.16                1.02 
Student t- test 0.61 (2.132)* 0.98 (2.132)* 
Variance ratio 
F-ratio 
1.77 (19)* 
1.3 (19)* 
 
 
 
Table 5: Application of the proposed method to the pharmaceutical preparation using pCA. 
Parameters Tablets Oral solution 
% Recovery 
Sigmadone (3 mg) Psychodal 
(c)
 
Proposed 
method 
Comparison method 
Proposed 
method 
Comparison 
method 
101.22 99.0 101.06 99.0 
101.33 101.00 98.40 101.00 
100.12 99.67 100 99.67 
 Mean 100.89 99.89 99.82 99.89 
± S.D. 0.67 1.02 1.34 1.02 
Student t- test 1.28 (2.132)* 0.187 (2.132)* 
Variance ratio F-ratio 2.23 (19)* 1.79 (19)* 
 
  * Values between ( ) are the tabulated t and f values respectively at P = 0.05 [21].     
Tablets:          (a) Riscure
®
 4 mg product of (GLOBAL NAPI PHARMACEUTICALS (GNP), Egypt), with batch ≠ 112521A. 
                        (b) Sigmadone
®
 3 mg product of (SIGMA pharmaceutical industries, Egypt, S.A.E.), with batch ≠ 00846. 
Oral solution: (c) Psychodal
®
 (DELTA PHARMA S.A.E., Egypt), each mL contains 1 mg RIS, with batch ≠ 11492. 
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Figure (1): Structure formula of Risperidone 
 
 
 
 
 
 
 
 
 
  
 
                              
Figure (2): job's plot for RIS-TCNQ complex (abs1) and RIS-pCA complex (abs2). 
 
                            
  (a)                                                                                  (b) 
 
Figure (3): absorption spectra of TCNQ (a) and pCA (b) with RIS. 
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